Induction of TGF-β1 Synthesis by Macrophages in Response to Apoptotic Cells Requires Activation of the Scavenger Receptor CD36

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Xiong, Weipeng ^a   Frasch, S Courtney ^a   Thomas, Stacey M ^a   Bratton, Donna L ^a   Henson, Peter M ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD36 ANTIBODY; CD36 ANTIGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLSERINE; PROTEIN KINASE LYN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE ACTIVATION; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD36; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; PROTEIN-SERINE-THREONINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SRC-FAMILY KINASES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84881019811     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072772     Document Type: Article

References (51)

1. deCathelineau AM, Henson PM, (2003) The final step in programmed cell death: phagocytes carry apoptotic cells to the grave. Essays Biochem 39: 105-117. PubMed: 14585077.
2. Gardai SJ, Bratton DL, Ogden CA, Henson PM, (2006) Recognition ligands on apoptotic cells: a perspective. J Leukoc Biol 79: 896-903. doi:10.1189/jlb.1005550. PubMed: 16641135.
3. Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, et al. (2005) Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123: 321-334. doi:10.1016/j.cell.2005.08.032. PubMed: 16239148.
4. Morimoto K, Janssen WJ, Fessler MB, McPhillips KA, Borges VM, et al. (2006) Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol 176: 7657-7665. PubMed: 16751413.
5. Vandivier RW, Henson PM, Douglas IS, (2006) Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 129: 1673-1682. doi:10.1378/chest.129.6.1673. PubMed: 16778289.
6. Freire-de-Lima CG, Xiao YQ, Gardai SJ, Bratton DL, Schiemann WP, et al. (2006) Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J Biol Chem 281: 38376-38384. doi:10.1074/jbc.M605146200. PubMed: 17056601.
7. Huynh ML, Fadok VA, Henson PM, (2002) Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 109: 41-50. doi:10.1172/JCI200211638. PubMed: 11781349.
8. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, et al. (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101: 890-898. doi:10.1172/JCI1112. PubMed: 9466984.
9. Park HJ, Choi YH, Cho YJ, Henson PM, Kang JL, (2011) RhoA-mediated signaling up-regulates hepatocyte growth factor gene and protein expression in response to apoptotic cells. J Leukoc Biol 89: 399-411. doi:10.1189/jlb.0710414. PubMed: 21148681.
10. Chin BY, Petrache I, Choi AM, Choi ME, (1999) Transforming growth factor beta1 rescues serum deprivation-induced apoptosis via the mitogen-activated protein kinase (MAPK) pathway in macrophages. J Biol Chem 274: 11362-11368. doi:10.1074/jbc.274.16.11362. PubMed: 10196228.
11. Dennler S, Goumans MJ, ten Dijke P, (2002) Transforming growth factor beta signal transduction. J Leukoc Biol 71: 731-740. PubMed: 11994497.
12. Feng XH, Derynck R, (2005) Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 21: 659-693. doi:10.1146/annurev.cellbio.21.022404.142018. PubMed: 16212511.
13. Huang Y, Hutter D, Liu Y, Wang X, Sheikh MS, et al. (2000) Transforming growth factor-beta 1 suppresses serum deprivation-induced death of A549 cells through differential effects on c-Jun and JNK activities. J Biol Chem 275: 18234-18242. doi:10.1074/jbc.M909431199. PubMed: 10748131.
14. Shi Y, Massagué J, (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700. doi:10.1016/S0092-8674(03)00432-X. PubMed: 12809600.
15. Xiao YQ, Freire-de-Lima CG, Schiemann WP, Bratton DL, Vandivier RW, et al. (2008) Transcriptional and translational regulation of TGF-beta production in response to apoptotic cells. J Immunol 181: 3575-3585. PubMed: 18714031.
16. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, et al. (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148: 2207-2216. PubMed: 1545126.
17. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, et al. (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182: 1545-1556. doi:10.1084/jem.182.5.1545. PubMed: 7595224.
18. McDonald PP, Fadok VA, Bratton D, Henson PM, (1999) Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells. J Immunol 163: 6164-6172. PubMed: 10570307.
19. Fadok VA, Bratton DL, Guthrie L, Henson PM, (2001) Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J Immunol 166: 6847-6854. PubMed: 11359844.
20. Fadok VA, de Cathelineau A, Daleke DL, Henson PM, Bratton DL, (2001) Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J Biol Chem 276: 1071-1077. doi:10.1074/jbc.M003649200. PubMed: 10986279.
21. Hoffmann PR, Kench JA, Vondracek A, Kruk E, Daleke DL, et al. (2005) Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J Immunol 174: 1393-1404. PubMed: 15661897.
22. Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, et al. (2007) Identification of Tim4 as a phosphatidylserine receptor. Nature 450: 435-439. doi:10.1038/nature06307. PubMed: 17960135.
23. Kobayashi N, Karisola P, Peña-Cruz V, Dorfman DM, Jinushi M, et al. (2007) TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 27: 927-940. doi:10.1016/j.immuni.2007.11.011. PubMed: 18082433.
24. Park D, Tosello-Trampont AC, Elliott MR, Lu M, Haney LB, et al. (2007) BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 450: 430-434. doi:10.1038/nature06329. PubMed: 17960134.
25. Park SY, Jung MY, Kim HJ, Lee SJ, Kim SY, et al. (2008) Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ 15: 192-201. doi:10.1038/sj.cdd.4402242. PubMed: 17962816.
26. Lemke G, Rothlin CV, (2008) Immunobiology of the TAM receptors. Nat Rev Immunol 8: 327-336. doi:10.1038/nri2303. PubMed: 18421305.
27. Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, et al. (2004) Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304: 1147-1150. doi:10.1126/science.1094359. PubMed: 15155946.
28. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, et al. (2002) Identification of a factor that links apoptotic cells to phagocytes. Nature 417: 182-187. doi:10.1038/417182a. PubMed: 12000961.
29. Akakura S, Singh S, Spataro M, Akakura R, Kim JI, et al. (2004) The opsonin MFG-E8 is a ligand for the alphavbeta5 integrin and triggers DOCK180-dependent Rac1 activation for the phagocytosis of apoptotic cells. Exp Cell Res 292: 403-416. doi:10.1016/j.yexcr.2003.09.011. PubMed: 14697347.
30. Febbraio M, Hajjar DP, Silverstein RL, (2001) CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108: 785-791. doi:10.1172/JCI200114006. PubMed: 11560944.
31. Tait JF, Smith C, (1999) Phosphatidylserine receptors: role of CD36 in binding of anionic phospholipid vesicles to monocytic cells. J Biol Chem 274: 3048-3054. doi:10.1074/jbc.274.5.3048. PubMed: 9915844.
32. Yamaguchi A, Yamamoto N, Akamatsu N, Saido TC, Kaneda M, et al. (2000) PS-liposome and ox-LDL bind to different sites of the immunodominant domain (#s155-183) of CD36: a study with GS95, a new anti-CD36 monoclonal antibody. Thromb Res 97: 317-326. doi:10.1016/S0049-3848(99)00179-6. PubMed: 10709907.
33. Fadok VA, Warner ML, Bratton DL, Henson PM, (1998) CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J Immunol 161: 6250-6257. PubMed: 9834113.
34. Greenberg ME, Sun M, Zhang R, Febbraio M, Silverstein R, et al. (2006) Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J Exp Med 203: 2613-2625. doi:10.1084/jem.20060370. PubMed: 17101731.
35. Yehualaeshet T, O'Connor R, Begleiter A, Murphy-Ullrich JE, Silverstein R, et al. (2000) A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat. Am J Respir Cell Mol Biol 23: 204-212. doi:10.1165/ajrcmb.23.2.4089. PubMed: 10919987.
36. Yehualaeshet T, O'Connor R, Green-Johnson J, Mai S, Silverstein R, et al. (1999) Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am J Pathol 155: 841-851. doi:10.1016/S0002-9440(10)65183-8. PubMed: 10487979.
37. Yang YL, Lin SH, Chuang LY, Guh JY, Liao TN, et al. (2007) CD36 is a novel and potential anti-fibrogenic target in albumin-induced renal proximal tubule fibrosis. J Cell Biochem 101: 735-744. doi:10.1002/jcb.21236. PubMed: 17226761.
38. Chen Y, Wang X, Weng D, Tao S, Lv L, et al. (2009) A TSP-1 functional fragment inhibits activation of latent transforming growth factor-beta1 derived from rat alveolar macrophage after bleomycin treatment. Exp Toxicol Pathol 61: 67-73. doi:10.1016/j.etp.2008.06.007. PubMed: 18722097.
39. Xie C, Ng H, Nagarajan S, (2011) OxLDL or TLR2-induced cytokine response is enhanced by oxLDL-independent novel domain on mouse CD36. Immunol Lett 137: 15-27. doi:10.1016/j.imlet.2011.01.015. PubMed: 21281677.
40. Erdman LK, Cosio G, Helmers AJ, Gowda DC, Grinstein S, et al. (2009) CD36 and TLR interactions in inflammation and phagocytosis: implications for malaria. J Immunol 183: 6452-6459. doi:10.4049/jimmunol.0901374. PubMed: 19864601.
41. Collins RF, Touret N, Kuwata H, Tandon NN, Grinstein S, et al. (2009) Uptake of oxidized low density lipoprotein by CD36 occurs by an actin-dependent pathway distinct from macropinocytosis. J Biol Chem 284: 30288-30297. doi:10.1074/jbc.M109.045104. PubMed: 19740737.
42. Hoffmann PR, deCathelineau AM, Ogden CA, Leverrier Y, Bratton DL, et al. (2001) Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol 155: 649-659. doi:10.1083/jcb.200108080. PubMed: 11706053.
43. Frasch SC, Henson PM, Nagaosa K, Fessler MB, Borregaard N, et al. (2004) Phospholipid flip-flop and phospholipid scramblase 1 (PLSCR1) co-localize to uropod rafts in formylated Met-Leu-Phe-stimulated neutrophils. J Biol Chem 279: 17625-17633. doi:10.1074/jbc.M313414200. PubMed: 14766753.
44. Patel SN, Lu Z, Ayi K, Serghides L, Gowda DC, et al. (2007) Disruption of CD36 impairs cytokine response to Plasmodium falciparum glycosylphosphatidylinositol and confers susceptibility to severe and fatal malaria in vivo. J Immunol 178: 3954-3961. PubMed: 17339496.
45. Silverstein RL, Febbraio M, (2009) CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2re3-: re3 PubMed: 19471024.
46. Williams NK, Lucet IS, Klinken SP, Ingley E, Rossjohn J, (2009) Crystal structures of the Lyn protein tyrosine kinase domain in its Apo- and inhibitor-bound state. J Biol Chem 284: 284-291. PubMed: 18984583.
47. Congleton J, MacDonald R, Yen A, (2012) Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells. Leukemia 26: 1180-1188. doi:10.1038/leu.2011.390. PubMed: 22182854.
48. Baranova IN, Kurlander R, Bocharov AV, Vishnyakova TG, Chen Z, et al. (2008) Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling. J Immunol 181: 7147-7156. PubMed: 18981136.
49. Moore KJ, El Khoury J, Medeiros LA, Terada K, Geula C, et al. (2002) A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J Biol Chem 277: 47373-47379. doi:10.1074/jbc.M208788200. PubMed: 12239221.
50. Rahaman SO, Lennon DJ, Febbraio M, Podrez EA, Hazen SL, et al. (2006) A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab 4: 211-221. doi:10.1016/j.cmet.2006.06.007. PubMed: 16950138.
51. Price MA, Cruzalegui FH, Treisman R, (1996) The p38 and ERK MAP kinase pathways cooperate to activate Ternary Complex Factors and c-fos transcription in response to UV light. EMBO J 15: 6552-6563. PubMed: 8978682.